Published ahead of print on November 5, 2004, doi:10.1164/rccm.200407-948OC
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 371-378, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200407-948OC
Ventilation Inhomogeneities in Relation to Standard Lung Function in Patients with Cystic Fibrosis
Richard Kraemer,
Andrea Blum,
Andreas Schibler,
Roland A. Ammann and
Sabina Gallati
Department of Pediatrics and Division of Human Genetics, University of Berne, Berne, Switzerland
Correspondence and requests for reprints should be addressed to Richard Kraemer, M.D., Professor and Chairman, Department of Pediatrics, University of Berne, Inselspital, Berne CH-3010, Switzerland. E-mail: richard.kraemer{at}insel.ch
Based on serial lung function measurements performed in 142 children (68 males; 74 females) with cystic fibrosis (CF), prospectively evaluated over an age range of 6 to 20 years, we attempted to determine whether the lung clearance index (LCI) as a measure of ventilation inhomogeneities could be a discriminating factor of disease progression. Annual follow-up lung function measurements featuring FRC determined by whole-body plethysmography and multibreath nitrogen washouts, effective specific airway resistance, flowvolume curves, LCI, and gas exchange characteristics were analyzed by linear mixed-model analysis and Kaplan-Meier statistics. The earliest occurring and strongest factor of progression was the LCI, followed by maximal expiratory flow (MEF50) and FRC determined by plethysmography (p < 0.0001). Associations between onset of chronic Pseudomonas aeruginosa infection and CF transmembrane conductance regulator (CFTR) genotype with FEV1 (p = 0.027) and FVC (p = 0.007) were identified. The study shows that the LCI predicts earlier in life and represented much better functional progression than FEV1. Moreover, there is no single functional predictor of progression in CF, but aside from risk factors, such as onset of chronic P. aeruginosa infection and genotype, pulmonary hyperinflation, airway obstruction, and ventilation inhomogeneities are important pathophysiologic processes that should be evaluated concomitantly as determinants of lung progression in CF.
Key Words: cystic fibrosis genotype onset of progression Pseudomonas aeruginosa ventilation inhomogeneities
This article has been cited by other articles:

|
 |

|
 |
 
A. Bush
Update in Pediatric Lung Disease 2007
Am. J. Respir. Crit. Care Med.,
April 1, 2008;
177(7):
686 - 695.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C Davies, S. Cunningham, E. W F W Alton, and J A Innes
Lung clearance index in CF: a sensitive marker of lung disease severity
Thorax,
February 1, 2008;
63(2):
96 - 97.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Latzin, C. Thamrin, and R. Kraemer
Ventilation inhomogeneities assessed by the multibreath washout (MBW) technique
Thorax,
February 1, 2008;
63(2):
98 - 99.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P M Gustafsson, P A De Jong, H A W M Tiddens, and A Lindblad
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
Thorax,
February 1, 2008;
63(2):
129 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R Horsley, P M Gustafsson, K A Macleod, C Saunders, A P Greening, D J Porteous, J C Davies, S Cunningham, E W F W Alton, and J A Innes
Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis
Thorax,
February 1, 2008;
63(2):
135 - 140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1304 - 1345.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lum, P. Gustafsson, H. Ljungberg, G. Hulskamp, A. Bush, S. B Carr, R. Castle, A.-f. Hoo, J. Price, S. Ranganathan, et al.
Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests
Thorax,
April 1, 2007;
62(4):
341 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bush
Update in Pediatric Lung Disease 2006
Am. J. Respir. Crit. Care Med.,
March 15, 2007;
175(6):
532 - 540.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z A Aziz, J C Davies, E W Alton, A U Wells, D M Geddes, and D M Hansell
Computed tomography and cystic fibrosis: promises and problems
Thorax,
February 1, 2007;
62(2):
181 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kraemer, N. Delosea, P. Ballinari, S. Gallati, and R. Crameri
Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
December 1, 2006;
174(11):
1211 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Accurso
Update in cystic fibrosis 2005.
Am. J. Respir. Crit. Care Med.,
May 1, 2006;
173(9):
944 - 947.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B D Callaghan, A F Hoo, R Dinwiddie, I M Balfour-Lynn, and S B Carr
Growth and lung function in Asian patients with cystic fibrosis
Arch. Dis. Child.,
October 1, 2005;
90(10):
1029 - 1032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Ranganathan and C. F. Robertson
Ventilation Inhomogeneities in Patients with Cystic Fibrosis: Inappropriate Reference Data and Errors?
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
645 - 645.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kraemer, R. A. Ammann, and S. Gallati
Ventilation Inhomogeneities in Patients with Cystic Fibrosis: Inappropriate Reference Data and Errors?
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
645 - 646.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|